Literature DB >> 16235182

Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications.

Charles B Beard1, Melissa R Fox, Gena G Lawrence, Jeannette Guarner, Randy L Hanzlick, Laurence Huang, Carlos del Rio, David Rimland, Jeffrey S Duchin, Daniel G Colley.   

Abstract

Polymerase chain reaction analysis, direct DNA sequencing, and histological staining were used to determine whether Pneumocystis jirovecii was present in lung tissue specimens obtained, at autopsy, from 58 infants without identifiable immunodeficiency. The results of genotyping of these specimens were compared with the results of genotyping of specimens obtained from 384 human immunodeficiency virus (HIV)-infected adults with Pneumocystis pneumonia. P. jirovecii DNA was detected at the mitochondrial large subunit rRNA and dihydropteroate synthase loci in 100% and 53%, respectively, of the specimens obtained from infants. All specimens obtained from adults tested positive for P. jirovecii at both loci. Genotype distributions at both loci were significantly different in the 2 populations (P < .0001). The observation of different strains circulating in immunocompetent infants and HIV-infected adults suggests independent transmission cycles that warrant further study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235182     DOI: 10.1086/497381

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

2.  High transient colonization by Pneumocystis jirovecii between mothers and newborn.

Authors:  Cristian Vera; Yudy A Aguilar; Lázaro A Vélez; Zulma Vanessa Rueda
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

Review 3.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

5.  Epidemiology of Pneumocystis colonization in families.

Authors:  LaShonda Spencer; Michelle Ukwu; Travis Alexander; Karri Valadez; Lora Liu; Toni Frederick; Andrea Kovacs; Alison Morris
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

Review 6.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

7.  Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.

Authors:  Su Young Kim; Alix A Dabb; Donald J Glenn; Kristen M Snyder; Meredith K Chuk; David M Loeb
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

8.  Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough.

Authors:  Ernesto X Monroy-Vaca; Yaxsier de Armas; María T Illnait-Zaragozí; Gilda Toraño; Raúl Diaz; Dania Vega; Ileana Alvarez-Lam; Enrique J Calderón; Christen R Stensvold
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

Review 9.  Clinical and translational research in pneumocystis and pneumocystis pneumonia.

Authors:  L Huang
Journal:  Parasite       Date:  2011-02       Impact factor: 3.000

10.  Pneumocystis pneumonia in HIV-positive adults, Malawi.

Authors:  Joep J G van Oosterhout; Miriam K Laufer; M Arantza Perez; Stephen M Graham; Nelson Chimbiya; Phillip C Thesing; Miriam J Alvarez-Martinez; Paul E Wilson; Maganizo Chagomerana; Eduard E Zijlstra; Terrie E Taylor; Christopher V Plowe; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.